Cisco Systems (NASDAQ:CSCO) has received an “AA” credit rating from Morningstar. The research firm’s “AA” rating indicates that the company is a very-low default risk. They also gave their stock a three star rating. Cisco Systems, Inc. (NASDAQ:CSCO) belongs to Technology sector. Its net profit margin is 16.70% and weekly performance is 0.97%. On last trading day company shares ended up $25.03. Cisco Systems, Inc. (NASDAQ:CSCO) distance from 50-day simple moving average (SMA50) is 0.60%.

Trina Solar Limited (NYSE:TSL) announced the pricing of its previously announced offering of 10,333,785 American Depositary Shares (“ADSs”), each representing 50 ordinary shares of the Company, par value of US$0.00001 per share (the “ADS Offering”), 2,504,000 of which (the “primary ADSs”) are being offered and sold by the Company and 7,829,785 of which (the “borrowed ADSs”) the Company will loan to affiliates of the underwriters of the Company’s concurrent offering of convertible senior notes (the “ADS Borrowers”), as described below. Trina Solar has also granted to the underwriters in the ADS Offering a 30-day option to purchase up to an additional 1,125,000 primary ADSs to cover over-allotments. Trina Solar Limited (NYSE:TSL) shares fell -5.55% in last trading session and ended the day at $11.40. TSL Gross Margin is 16.40% and its return on assets is 2.30%. Trina Solar Limited (NYSE:TSL) quarterly performance is -7.32%.

Summer Street restated their buy rating on shares of Rockwell Medical (NASDAQ:RMTI) in a research note issued to investors on Friday. On 01 October, Rockwell Medical, Inc. (NASDAQ:RMTI) shares fell -2.84% and was closed at $8.88. RMTI EPS growth in last 5 year was -21.00%. Rockwell Medical, Inc. (NASDAQ:RMTI) year to date (YTD) performance is -14.94%.

TheStreet Ratings team rates 3D Systems Corporation (NYSE:DDD) as a Hold with a ratings score of C. 3D Systems Corporation (NYSE:DDD) ended the last trading day at $44.54. Company weekly volatility is calculated as 3.38% and price to cash ratio as 8.58. 3D Systems Corporation (NYSE:DDD) showed a weekly performance of -10.09%.

Genocea Biosciences (NASDAQ:GNCA) VP Jessica Baker Flechtner sold 6,435 shares of the company’s stock in a transaction that occurred on Friday, September 12th. The shares were sold at an average price of $12.00, for a total transaction of $77,220.00. Following the transaction, the vice president now directly owns 1,680 shares in the company, valued at approximately $20,160. Genocea Biosciences, Inc. (NASDAQ:GNCA) shares moved up 0.22% in last trading session and ended the day at $9.07. GNCA return on assets is -66.00%. Genocea Biosciences, Inc. (NASDAQ:GNCA) quarterly performance is -48.50%.